axitinib,belzutifan
pfizer,merck
['belzutifan', 'axitinib']
 a few qs spring to mind 1. what was the mix of prognostic subgroups? 2. were the dose reductions for cabo, belzutifan or both? is the starting dose wrong? i still haven t worked out why companies don t employ a dose titration schedule like that which was done with axitinib
Medical oncologist from Perth - Australia. Interested in thoracic oncology, breast cancer, GUs, clinical trials, fast cars (Formula 1) and @werderbremen_en